Helen Dakin

3.0k total citations
70 papers, 2.0k citations indexed

About

Helen Dakin is a scholar working on Economics and Econometrics, Surgery and Sociology and Political Science. According to data from OpenAlex, Helen Dakin has authored 70 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 18 papers in Surgery and 12 papers in Sociology and Political Science. Recurrent topics in Helen Dakin's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Delphi Technique in Research (12 papers) and Total Knee Arthroplasty Outcomes (11 papers). Helen Dakin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Delphi Technique in Research (12 papers) and Total Knee Arthroplasty Outcomes (11 papers). Helen Dakin collaborates with scholars based in United Kingdom, Netherlands and Norway. Helen Dakin's co-authors include Alastair Gray, Nancy Devlin, Ray Fitzpatrick, Sarah Wordsworth, Graeme MacLennan, Isaac Odeyemi, David W. Murray, Stavros Petrou, David Parkin and Nigel Rice and has published in prestigious journals such as Diabetes Care, Journal of Bone and Joint Surgery and Social Science & Medicine.

In The Last Decade

Helen Dakin

68 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Dakin United Kingdom 26 767 559 298 230 208 70 2.0k
Craig Fleming United States 18 530 0.7× 527 0.9× 405 1.4× 248 1.1× 89 0.4× 40 2.6k
Laura Pizzi United States 20 172 0.2× 237 0.4× 407 1.4× 178 0.8× 80 0.4× 52 1.4k
Derek Kyte United Kingdom 26 618 0.8× 298 0.5× 427 1.4× 331 1.4× 73 0.4× 70 2.3k
Antonio Escobar Spain 28 391 0.5× 2.3k 4.1× 544 1.8× 393 1.7× 662 3.2× 105 4.0k
Ágota Szende United Kingdom 14 751 1.0× 297 0.5× 440 1.5× 265 1.2× 65 0.3× 42 2.0k
Kok‐Yong Fong Singapore 26 478 0.6× 268 0.5× 298 1.0× 251 1.1× 439 2.1× 43 1.7k
Stefan Schandelmaier Switzerland 17 198 0.3× 332 0.6× 303 1.0× 237 1.0× 86 0.4× 45 1.7k
Anuja Roy United States 11 344 0.4× 142 0.3× 148 0.5× 167 0.7× 137 0.7× 41 2.2k
Anita Burrell United States 9 383 0.5× 139 0.2× 129 0.4× 156 0.7× 140 0.7× 22 2.0k
Rachel Court United Kingdom 21 73 0.1× 563 1.0× 151 0.5× 213 0.9× 213 1.0× 66 1.8k

Countries citing papers authored by Helen Dakin

Since Specialization
Citations

This map shows the geographic impact of Helen Dakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Dakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Dakin more than expected).

Fields of papers citing papers by Helen Dakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Dakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Dakin. The network helps show where Helen Dakin may publish in the future.

Co-authorship network of co-authors of Helen Dakin

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Dakin. A scholar is included among the top collaborators of Helen Dakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Dakin. Helen Dakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dakin, Helen, et al.. (2024). Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management. PharmacoEconomics. 42(9). 1017–1028. 1 indexed citations
3.
Dakin, Helen & Apostolos Tsiachristas. (2024). Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?. Applied Health Economics and Health Policy. 22(3). 315–329. 1 indexed citations
4.
5.
Lim, Lee‐Ling, Helen Dakin, John Buckell, et al.. (2023). Trends in all-cause mortality among adults with diagnosed type 2 diabetes in West Malaysia: 2010 – 2019. Diabetes Research and Clinical Practice. 205. 110944–110944. 3 indexed citations
6.
Roope, Laurence, Feisul Idzwan Mustapha, Chiu‐Wan Ng, et al.. (2023). Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia. Social Science & Medicine. 340. 116426–116426. 1 indexed citations
7.
Dakin, Helen, Ines Rombach, Melina Dritsaki, et al.. (2022). Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease. Bone & Joint Open. 3(11). 898–906. 4 indexed citations
8.
Hopewell, Sally, David J. Keene, Peter Heine, et al.. (2021). Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT. Health Technology Assessment. 25(48). 1–158. 19 indexed citations
9.
Dakin, Helen & Alastair Gray. (2020). Which interactions matter in economic evaluations? A systematic review and simulation study. BMC Medical Research Methodology. 20(1). 109–109. 1 indexed citations
10.
Dakin, Helen, José Leal, Andrew Briggs, et al.. (2020). Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data. Medical Decision Making. 40(4). 460–473. 16 indexed citations
11.
12.
13.
Dakin, Helen, Alastair Gray, Graeme MacLennan, Richard Morris, & David W. Murray. (2018). Partial factorial trials: comparing methods for statistical analysis and economic evaluation. Trials. 19(1). 442–442. 7 indexed citations
14.
Dakin, Helen, Lucy Abel, Richéal Burns, & Yaling Yang. (2018). Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement. Health and Quality of Life Outcomes. 16(1). 31–31. 82 indexed citations
15.
16.
Dakin, Helen & Alastair Gray. (2017). Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations. Statistics in Medicine. 36(18). 2814–2830. 20 indexed citations
17.
Dixon, Padraig, Helen Dakin, & Sarah Wordsworth. (2015). Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L. Quality of Life Research. 25(4). 935–945. 7 indexed citations
18.
Petrou, Stavros, Oliver Rivero‐Arias, Helen Dakin, et al.. (2015). The Maps Reporting Statement for Studies Mapping onto Generic Preference-Based outcome Measures. Value in Health. 18(7). A715–A716. 2 indexed citations
19.
Petrou, Stavros, Oliver Rivero‐Arias, Helen Dakin, et al.. (2015). PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT. International Journal of Technology Assessment in Health Care. 31(4). 230–235. 6 indexed citations
20.
Liedgens, Hiltrud, Gabriel Abbam, Mark Nuijten, et al.. (2008). Cost-Effectiveness Analysis of a Lidocaine 5% Medicated Plaster Compared with Gabapentin and Pregabalin for Treating Postherpetic Neuralgia. Clinical Drug Investigation. 28(9). 583–601. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Fleming Breakdown of academic impact, for papers by Laura Pizzi Breakdown of academic impact, for papers by Derek Kyte Breakdown of academic impact, for papers by Antonio Escobar Breakdown of academic impact, for papers by Ágota Szende Breakdown of academic impact, for papers by Kok‐Yong Fong Breakdown of academic impact, for papers by Stefan Schandelmaier Breakdown of academic impact, for papers by Anuja Roy Breakdown of academic impact, for papers by Anita Burrell Breakdown of academic impact, for papers by Rachel Court
Rankless by CCL
2026